Psychotherapy + MIDOMAFETAMINE for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 17 May 2024: Trial registered, NCT06418178
  2. 3 Jun 2025: Trial started, NCT06418178

The trials

NCT06353282: MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents

State
Withdrawn before it started
Phase
Phase 2
People
0 taking part
Started
1 Jul 2025
Primary completion
31 Jan 2026
Arms
MDMA Psychotherapy
Results
None posted
  1. 9 Apr 2024: Trial registered
  2. 10 Apr 2025: Trial withdrawn

NCT06418178: Dose Optimization of MDMA-Assisted Therapy for PTSD

State
Under way
Phase
Phase 2
People
60 planned
Started
3 Jun 2025
Primary completion
Oct 2029
Arms
Treatment Arm
Results
None posted
  1. 17 May 2024: Trial registered
  2. 3 Jun 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.